A Study to Evaluate the Pharmacokinetics and Safety of Loncastuximab Tesirine in Participants With Relapsed or Refractory Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma With Hepatic Impairment (LOTIS-10)
Clinical trial NCT05660395 · TERMINATED
Trial details
- NCT number
- NCT05660395
- Sponsor
- ADC Therapeutics S.A.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2026-06-25
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.